Identification and functional validation of novel pharmacogenomic variants using a next-generation sequencing-based approach for clinical pharmacogenomics.

MLA

Siamoglou, Stavroula, et al. “Identification and Functional Validation of Novel Pharmacogenomic Variants Using a Next-Generation Sequencing-Based Approach for Clinical Pharmacogenomics.” Pharmacological Research, vol. 176, Feb. 2022, p. 106087. EBSCOhost, https://doi.org/10.1016/j.phrs.2022.106087.

APA

Siamoglou, S., Koromina, M., Hishinuma, E., Yamazaki, S., Tsermpini, E.-E., Kordou, Z., Fukunaga, K., Chantratita, W., Zhou, Y., Lauschke, V. M., Mushiroda, T., Hiratsuka, M., & Patrinos, G. P. (2022). Identification and functional validation of novel pharmacogenomic variants using a next-generation sequencing-based approach for clinical pharmacogenomics. Pharmacological Research, 176, 106087. https://doi.org/10.1016/j.phrs.2022.106087

Chicago

Siamoglou, Stavroula, Maria Koromina, Eiji Hishinuma, Shuki Yamazaki, Evangelia-Eirini Tsermpini, Zoe Kordou, Koya Fukunaga, et al. 2022. “Identification and Functional Validation of Novel Pharmacogenomic Variants Using a Next-Generation Sequencing-Based Approach for Clinical Pharmacogenomics.” Pharmacological Research 176 (February): 106087. doi:10.1016/j.phrs.2022.106087.